UBX250117P2000
- 0.40
- 0.000.00%
Unity Biotechnology Newsroom
UNITY Biotechnology Reports Granting of New Employment Inducement Award
Unity Biotechnology Names Federico Grossi Chief Medical Officer, Pre-market Stock Rises
Express News | UNITY Biotechnology Announces Appointment of Federico Grossi, M.d., Ph.d., as Chief Medical Officer
Press Release: UNITY Biotechnology Announces Appointment of Federico Grossi, M.D., Ph.D., as Chief Medical Officer
UNITY Biotechnology Announces Appointment of Federico Grossi, M.D., Ph.D., as Chief Medical Officer
We're Keeping An Eye On Unity Biotechnology's (NASDAQ:UBX) Cash Burn Rate
Unity Biotechnology Focuses on Promising DME Treatment
Unity Biotechnology GAAP EPS of -$0.38 Beats by $0.02
Express News | Unity Biotechnology Q3 2024 GAAP EPS $(0.38) Beats $(0.40) Estimate
Unity Biotechnology | 10-Q: Q3 2024 Earnings Report
Unity Biotechnology | 8-K: UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates
Express News | UNITY Biotechnology Inc: UNITY Expects Topline 24-Week Primary Endpoint Data in Q1 of 2025 and 36-Week Data in Q2 of 2025
Unity Biotechnology 3Q Loss/Shr 38c >UBX
Press Release: UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates
Express News | UNITY Biotechnology Q3 Net Income USD -6.481 Million
Express News | UNITY Biotechnology Q3 Operating Expenses USD 6.602 Million
UNITY Biotechnology to Host In-Person Ophthalmology Day in New York on Tuesday, October 15, 2024
Hard Rock and John Legend 'Come Together for Good' at Special Performance for Unity by Hard Rock Members
Rodman & Renshaw Maintains Unity Biotechnology(UBX.US) With Buy Rating, Cuts Target Price to $8
Express News | Rodman & Renshaw Initiates Coverage On Unity Biotechnology With Buy Rating, Announces Price Target of $8